Anaphylaxis Treatment Market worth USD xx million by 2025

Posted by venkatakiran on September 30th, 2019

Anaphylaxis Treatment Market Size and Growth Rate:

“The Global Anaphylaxis Treatment Market was valued around US$XX Mn by 2018 and growing at a CAGR of XX% over next seven years 2019-2025 due to rising incidence  of anaphylaxis across the world”

Anaphylaxis Treatment Market Growth Drivers and Restraints:

The global Anaphylaxis Treatment market accounted for US$ XX Mn in 2018 and burgeoning over the forthcoming years. Majority of incidence of anaphylaxis found in western developed countries, growing awareness among the patients regarding treatment options for anaphylaxis reactions are some the key factors fostering the market growth. However, lack of awareness regarding the treatment in most of the underdeveloped regions and side effects caused by the drugs in the treatment of anaphylaxis are inhibiting the market growth.

Browse More Details of the report @https://www.precisionbusinessinsights.com/market-reports/global-anaphylaxis-treatment-market/

Anti-Histamines dominate the Global Anaphylaxis Treatment Market

Based on drug class, global Anaphylaxis Treatment market is segmented into adrenergic agents (epinephrine), anti-histamines and others. Anti-Histamines held considerable market growth during estimated period. Antihistamines are drugs which treat allergic rhinitis and other allergies by blocking the effects of histamines. The antihistamines are widely used to treat symptoms of allergic conditions including itching, nasal stuffiness, runny nose, teary eyes, urticaria, dizziness, nausea and cough. They are useful for treating the itching that results from the release of histamine. Antihistamines come as pills, chewable tablets, capsules, and liquids.

North America Leads the Global Anaphylaxis Treatment market

PBI’s global Anaphylaxis Treatment market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis. North America accounted for larger revenue share in global Anaphylaxis Treatment market with considerable CAGR. The growth of this region can be attributed to rise in death rates caused by anaphylaxis reaction to foods among the people in this region and changing lifestyles of the people.

Strategic New Product Launches are the Key Strategies Adopted by Market Players

Global Anaphylaxis Treatment market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For Instance, in 2019, Sandoz extended SYMJEPI™ (epinephrine) Injection launch to US pharmacies to help improve patient access to life-saving medicine. SYMJEPI™ (epinephrine) 0.3 mg and 0.15 mg injections, make both the adult and pediatric doses immediately available in local pharmacies across the nation.

Key player’s profiles in the report are ALK-Abelló (Denmark), Impax Laboratories Inc. (U.S.), Lincoln Medical Ltd. (New Zealand), Mylan NV (U.S.), Adamis Pharmaceutical Corporation (U.S.), MannKind Corporation (U.S.), Pfizer Inc. (U.S.), GlaxoSmithKline Plc. (U.K), Merck & Co., Inc. (U.S.).

Avail Sample of the report for more information @ https://www.precisionbusinessinsights.com/request-sample?product_id=15522

Detailed Segmentation of Anaphylaxis Treatment Market:

By Route of Administration       

o     Parenteral

o     Oral

o     Others

By Drug Class

o     Adrenergic Agents (Epinephrine)

o     Anti-Histamines

o     Others

By Distribution Channel              

o     Hospital Pharmacies

o     Retail Pharmacies

o     Online Pharmacies

By Geography

o     North America

o     Europe

o     Asia-Pacific

o     Latin America

o     Middle East and Africa (MEA)

About Us:

Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.

Contact Us:

Shreya Paul

Senior Business Development Executive

Email @ shreya@precisionbusinessinsights.com

Call @ +1-866-598-1553

Precision Business Insights